Quantcast
Home > Quotes > VLRX
VLRX

Valeritas Holdings, Inc. Common Stock (VLRX) Quote & Summary Data

$2.96
*  
0.10
3.27%
Get VLRX Alerts
*Delayed - data as of Jun. 14, 2019  -  Find a broker to begin trading VLRX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
25
Today's High / Low
$ 3.0499 / $ 2.8959
Share Volume
89,748
50 Day Avg. Daily Volume
373,311
Previous Close
$ 3.06
52 Week High / Low
$ 41.60 / $ 2.10
Market Cap
15,714,983
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.77

Special Dividend Data

Special Dividend
N/A
Special Dividend Date
May 20, 2019
Special Dividend Payment Date
N/A

Intraday Chart

Shares Traded

Share Volume:
89,748
50 Day Avg. Daily Volume:
373,311

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -29.20

Trading Range

The current last sale of $2.96 is 40.95% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 3.0499 $ 41.60
 Low: $ 2.8959 $ 2.10

Company Description (as filed with the SEC)

On May 3, 2016, pursuant to an Agreement and Plan of Merger and Reorganization, or the Merger Agreement, by and among Valeritas Holdings, Inc., a Delaware Corporation, Valeritas Acquisition Corp., a Delaware corporation and a direct wholly-owned subsidiary of Valeritas Holdings, Inc., or the Acquisition Subsidiary, and Valeritas, Inc., a Delaware Corporation, Acquisition Subsidiary was merged with and into Valeritas, with Valeritas surviving as a direct wholly-owned subsidiary of Valeritas Holdings, Inc. As used in this Annual Report on Form 10-K, unless otherwise stated or the context otherwise indicates, references to "Valeritas," the "Company," "we," "our," "us" or similar terms refer to Valeritas Holdings, Inc. and its subsidiary Valeritas, Inc. Overview We are a commercial-stage medical technology company, focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies.  ... More ...  



Risk Grade

Where does VLRX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 3.03
Open Date:
Jun. 14, 2019
Close Price:
$ 2.96
Close Date:
Jun. 14, 2019


Consensus Recommendation

Analyst Info